| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.23 | 0.003 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.004 |